A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARSLANI, Ketina et al. Cardiovascular imaging following perioperative myocardial infarction/injury. Scientific reports, v. 12, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-08261-6. Acesso em: 06 set. 2024.
APA
Arslani, K., Gualandro, D. M., Puelacher, C., Buse, G. L., Lampart, A., Bolliger, D., et al. (2022). Cardiovascular imaging following perioperative myocardial infarction/injury. Scientific reports, 12( 1). doi:10.1038/s41598-022-08261-6
NLM
Arslani K, Gualandro DM, Puelacher C, Buse GL, Lampart A, Bolliger D, Schulthess D, Glarner N, Hidvegi R, Caramelli B. Cardiovascular imaging following perioperative myocardial infarction/injury [Internet]. Scientific reports. 2022 ; 12( 1):[citado 2024 set. 06 ] Available from: https://doi.org/10.1038/s41598-022-08261-6
Vancouver
Arslani K, Gualandro DM, Puelacher C, Buse GL, Lampart A, Bolliger D, Schulthess D, Glarner N, Hidvegi R, Caramelli B. Cardiovascular imaging following perioperative myocardial infarction/injury [Internet]. Scientific reports. 2022 ; 12( 1):[citado 2024 set. 06 ] Available from: https://doi.org/10.1038/s41598-022-08261-6
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONIKOWSKI, Piotr et al. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure. European journal of heart failure, v. 21, n. 12, p. 1651-1658, 2019Tradução . . Disponível em: https://doi.org/10.1002/ejhf.1710. Acesso em: 06 set. 2024.
APA
Ponikowski, P., Kirwan, B. -A., Anker, S. D., Dorobantu, M., Drozdz, J., Fabien, V., et al. (2019). Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure. European journal of heart failure, 21( 12), 1651-1658. doi:10.1002/ejhf.1710
NLM
Ponikowski P, Kirwan B-A, Anker SD, Dorobantu M, Drozdz J, Fabien V, Filippatos G, Haboubi T, Keren A, Nicolau JC. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure [Internet]. European journal of heart failure. 2019 ; 21( 12): 1651-1658.[citado 2024 set. 06 ] Available from: https://doi.org/10.1002/ejhf.1710
Vancouver
Ponikowski P, Kirwan B-A, Anker SD, Dorobantu M, Drozdz J, Fabien V, Filippatos G, Haboubi T, Keren A, Nicolau JC. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure [Internet]. European journal of heart failure. 2019 ; 21( 12): 1651-1658.[citado 2024 set. 06 ] Available from: https://doi.org/10.1002/ejhf.1710